[1]Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021,71(3):209-249.
[2]Dekker E, Tanis PJ, Vleugels JL, et al. Colorectal cancer[J]. Lancet, 2019,394(10207):1467-1480.
[3]赵昕辉,刘俊,贺奋飞,等.基于生物信息学分析的结肠癌枢纽基因筛选及调控网络构建[J].现代肿瘤医学,2019,27(13):2227-2231.
[4]丁志祥, 史兵伟, 王永仿,等. 基于生物信息学对结肠癌潜在枢纽基因的筛选及验证[J]. 中国免疫学杂志, 2021, 37(2): 201-205.
[5]Chin CH, Chen SH, Wu HH, et al. CytoHubba: identifying hub objects and subnetworks from complex interactome[J]. BMC Syst Biol, 2014, 8(Suppl 4): S11.
[6]Dastsooz H, Cereda M, Donna D, et al. A comprehensive bioinformatics analysis of UBE2C in cancers[J]. Int J Mol Sci, 2019,20(9):2228.
[7]Ha TK, Chi SG. CAV1/caveolin 1 enhances aerobic glycolysis in colon cancer cells via activation of SLC2A3/GLUT3 transcription[J]. Autophagy, 2012, 8(11): 1684-1685.
[8]陈玉昌, 吴秋菊. 结肠癌中miR592、SOX9的表达与临床病理特征及预后的关系[J]. 海南医学, 2020, 31(13): 1644-1648.
[9]许学文,宋廉,杨晓晓,等. CXCL12CXCR4轴促进胶质母细胞瘤前神经间质转化[J].江苏大学学报(医学版), 2020,30(1):18-23.
[10]Yu XF, Wang D, Wang XH, et al. CXCL12/CXCR4 promotes inflammationdriven colorectal cancer progression through activation of RhoA signaling by sponging miR133a3p[J]. J Exp Clin Cancer Res, 2019, 38(1):32.
[11]Zhang R, Xu J, Zhao J, et al. Proliferation and invasion of colon cancer cells are suppressed by knockdown of TOP2A[J]. J Cell Biochem, 2018, 119(9): 7256-7263.
[12]Wang C, Xue WH, Zhang HH, et al. Identification of candidate genes encoding tumorspecific neoantigens in early and latestage colon adenocarcinoma[J]. Aging(Albany NY), 2021,13(3): 4024-4044.
[13]Cheng SJ, Castillo V, Sliva D. CDC20 associated with cancer metastasis and novel mushroomderived CDC20 inhibitors with antimetastatic activity[J]. Int J Oncol, 2019, 54(6): 2250-2256.
[14]Wu WJ, Hu KS, Wang DS, et al. CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer[J]. J Transl Med, 2013, 11: 142.
[15]Wang QY, Shi LS, Shi K, et al. CircCSPP1 functions as a ceRNA to promote colorectal carcinoma cell EMT and liver metastasis by upregulating COL1A1[J]. Front Oncol, 2020, 10: 850.
[16]Takahashi Y, Sheridan P, Niida A, et al. The AURKA/TPX2 axis drives colon tumorigenesis cooperatively with MYC[J]. Ann Oncol, 2015, 26(5): 935-942.
[17]WangBishop L, Chen Z, Gomaa A, et al. Inhibition of AURKA reduces proliferation and survival of gastrointestinal cancer cells with activated KRAS by preventing activation of RPS6KB1[J]. Gastroenterology, 2019, 156(3): 662-675.
[18]Shan BC, Zhao R, Zhou J, et al. AURKA increase the chemosensitivity of colon cancer cells to oxaliplatin by inhibiting the TP53mediated DNA damage response genes[J]. Biomed Res Int, 2020, 2020: 8916729.
[19]Koh HM, Jang BG, Hyun CL, et al. Aurora kinase A is a prognostic marker in colorectal adenocarcinoma[J]. J Pathol Transl Med, 2017, 51(1): 32-39.
[20]Song GH, Xu SF, Zhang H, et al. TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAKPI3K/AKT and MAPK pathway[J]. J Exp Clin Cancer Res, 2016, 35(1): 148. |